People: Merck & Co Inc (MRK.N)

MRK.N on New York Stock Exchange

59.88USD
17 Sep 2014
Price Change (% chg)

$-0.11 (-0.18%)
Prev Close
$59.99
Open
$59.70
Day's High
$60.00
Day's Low
$59.28
Volume
2,629,189
Avg. Vol
2,607,141
52-wk High
$61.33
52-wk Low
$44.62

Search Stocks

Rosenblatt, Michael 

Brief Biography

Dr. Michael Rosenblatt, M.D., is Executive Vice President, Chief Medical Officer of Merck & Co., Inc. He is responsible for the Company’s primary voice to the global medical community on critical issues such as patient safety and oversight for the Company’s Global Center for Scientific Affairs. Prior to December 2009, Dr. Rosenblatt was the Dean of Tufts University School of Medicine since 2003.

Basic Compensation

Total Annual Compensation, Long-Term Incentive Plans, All Other, Fiscal Year Total,
-- -- -- --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Search Stocks